FIELD: chemistry.
SUBSTANCE: group of inventions relates to the chemical-pharmaceutical industry and is an antitumour and antimetastatic agent possessing anti-inflammatory and anti-allergenic action, which is 2-isobutyl-4,6-dimethyl-5-oxypyrimidine hydrochloride of formula 1
. Invention also includes use of compound of formula 1 as an antitumour agent for adjuvant anticancer immunotherapy together with doxorubicin, as well as an antiallergenic preventive agent in seasonal allylic infections. Group of inventions provides higher anti-tumor activity and can be used as an independent anticancer agent and simultaneous increase in the effectiveness of cytostatic treatment of oncological patients.
EFFECT: new agent has no undesirable side effects inherent in fluorinated pyrimidines and anthracycline antibiotics.
3 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
5-OXYPYRIMIDINE DERIVATIVE POSSESSING ANTINEOPLASTIC ACTIVITY | 2011 |
|
RU2518889C2 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
AGENT FOR CORRECTION OF CYTOSTATIC POLYCHEMOTHERAPY WITH ANTI-INFLAMMATORY ACTIVITY | 2010 |
|
RU2425680C1 |
N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
Authors
Dates
2019-04-30—Published
2018-07-20—Filed